Highly commended
Incisive Health
Summary of work
2024 was a hugely successful year for Incisive Health. The company delivered revenue growth of over 10%, supported by major wins across its UK, international and Brussels practices.
Heading into the year, there was a risk that heightened political uncertainty across the world, with elections due to be held in over 50 countries, could lead to clients taking a cautious approach, pausing or delaying investment.
But change also creates opportunities. Incisive leveraged its core strengths in policy and political analysis, supporting clients to overcome volatility, cut through the noise and make an impact – securing the rollout of a test that can help early detection of cancer, working with the NHS to address cancer inequalities and amplifying patient voices in Alzheimer’s R&D.
To enable this success, Incisive enhanced its team’s capacity and capabilities, developed a new combined comms and policy offer and refreshed its market proposition to showcase the complementary strengths of its different practices.
Above all, the events of 2024 reinforced how much policy matters and how communications shape our world – Incisive Health is proud to support clients to highlight the importance of collaboration and investment to improve health across the UK, Europe and the world.
Judges’ comments
Judges were really impressed with Incisive Health. The judges liked that they started in policy and moved into communications. Many companies do it the other way round. This really set them apart from other entries. They’re a well-oiled machine and it was really noted that they have managed to transition from the UK to International.
